What Steps Should be Taken to Integrate Marijuana into Pain Regimens?

Abstract

Pain ManagementVol. 5, No. 4 OpinionWhat steps should be taken to integrate marijuana into pain regimens?Mark Wallace & Timothy FurnishMark Wallace*Author for correspondence: E-mail Address: mswallace@ucsd.edu Division of Pain Medicine, Department of Anesthesiology, UCSD School of Medicine, 9300 Campus Point Drive, #7651, La Jolla, CA 92037, USASearch for more papers by this author & Timothy Furnish Division of Pain Medicine, Department of Anesthesiology, UCSD School of Medicine, 9300 Campus Point Drive, #7651, La Jolla, CA 92037, USASearch for more papers by this authorPublished Online:19 Jun 2015https://doi.org/10.2217/pmt.15.20AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInRedditEmail View articleKeywords: clinicalmedicinalmarijuanapracticeReferences1 Abrams DI, Jay CA, Shade SB et al. Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial. Neurology 68(7), 515–521 (2007).Crossref, Medline, CAS, Google Scholar2 Ellis RJ, Toperoff W, Vaida F et al. Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial. Neuropsychopharmacology 34(3), 672–680 (2009).Crossref, Medline, CAS, Google Scholar3 Ware MA, Wang T, Shapiro S et al. Smoked cannabis for chronic neuropathic pain: a randomized controlled trial. CMAJ 182(14), E694–E701 (2010).Crossref, Medline, Google Scholar4 Wilsey B, Marcotte T, Deutsch R et al. Low-dose vaporized cannabis significantly improves neuropathic pain. J. Pain 14(2), 136–148 (2013).Crossref, Medline, CAS, Google Scholar5 Wilsey B, Marcotte T, Tsodikov A et al. A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain. J. Pain 9(6), 506–521 (2008).Crossref, Medline, CAS, Google Scholar6 Physician recommendation of medical cannabis: guidelines of the Council on Scientific Affairs subcommittee on medical marijuana practice advisory (2011). www.mbc.ca.gov/Licensees/Prescribing/medical_marijuana_cma-recommend.pdf.Google Scholar7 Wang T, Collet JP, Shapiro S, Ware MA. Adverse effects of medical cannabinoids: a systematic review. CMAJ 178(13), 1669–1678 (2008).Crossref, Medline, Google Scholar8 Aryana A, Williams MA. Marijuana as a trigger of cardiovascular events: speculation or scientific certainty? Int. J. Cardiol. 118(2), 141–144 (2007).Crossref, Medline, Google Scholar9 Abrams DI, Vizoso HP, Shade SB et al. Vaporization as a smokeless cannabis delivery system: a pilot study. Clin. Pharmacol. Ther. 82(5), 572–578 (2007).Crossref, Medline, CAS, Google Scholar10 23 Legal medical marijuana states and DC: laws, fees, and possession limits. http://medicalmarijuana.procon.org/view.resource.php?resourceID=000881.Google Scholar11 Elikkottil J, Gupta P, Gupta K. The analgesic potential of cannabinoids. J. Opioid Manag. 5(6), 341–357 (2009).Crossref, Medline, Google Scholar12 Reisfield GM, Wasan AD, Jamison RN. The prevalence and significance of cannabis use in patients prescribed chronic opioid therapy: a review of the extant literature. Pain Med. 10(8), 1434–1441 (2009).Crossref, Medline, Google Scholar13 Borgelt LM, Franson KL, Nussbaum AM, Wang GS. The pharmacologic and clinical effects of medical cannabis. Pharmacotherapy 33(2), 195–209 (2013).Crossref, Medline, CAS, Google Scholar14 Grant I, Atkinson JH, Gouaux B, Wilsey B. Medical marijuana: clearing away the smoke. Open Neurol. J. 6, 18–25 (2012).Crossref, Medline, Google ScholarFiguresReferencesRelatedDetailsCited ByRational Urine Drug Monitoring in Patients Receiving Opioids for Chronic Pain: Consensus Recommendations1 December 2017 | Pain Medicine, Vol. 19, No. 1 Vol. 5, No. 4 Follow us on social media for the latest updates Metrics Downloaded 48 times History Published online 19 June 2015 Published in print July 2015 Information© Future Medicine LtdKeywordsclinicalmedicinalmarijuanapracticeFinancial & competing interests disclosureThe authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.No writing assistance was utilized in the production of this manuscript.PDF download